An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines
- PMID: 34918241
- DOI: 10.1007/978-1-0716-1892-9_4
An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines
Abstract
In this chapter, we review the computational approaches that have led to a new generation of vaccines in recent years. There are many alternative routes to develop vaccines based on the concept of reverse vaccinology. They all follow the same basic principles-mining available genome and proteome information for antigen candidates, and recombinantly expressing them for vaccine production. Some of the same principles have been used successfully for cancer therapy approaches. In this review, we focus on infectious diseases, describing the general workflow from bioinformatic predictions of antigens and epitopes down to examples where such predictions have been used successfully for vaccine development.
Keywords: Core genome; Epitope prediction; Peptide epitopes; Reverse vaccinology; Surface proteins; Vaccine design.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Janeway CAJ, Travers P, Walport M et al (2001) Immunobiology. Garland Science, New York
-
- Alberts B, Johnson A, Walter P et al (2007) Molecular biology of the cell. Francis, Taylor &
-
- Neumann J (2008) Immunbiologie. Springer-Lehrbuch, Berlin, Heidelberg
-
- Saha B (2001) Encyclopedia of life sciences. John Wiley & Sons, Ltd, Chichester, UK
-
- WHO UNICEF World Bank (2009) State of the world’s vaccines and immunization. World Health Organization, Geneva
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
